Inhalation Anesthesia Using Physiologically Based Pharmacokinetic Models

References

• Eger E. I., II. A mathematical model of uptake and distribution. Uptake and Distribution of Anesthetic Agents, E. M. Papper, R. J. Kitz. McGraw-Hill, New York 1963; 72–87
   Google Scholar
• Mapleson W. W. Quantitative prediction of anesthetic concentrations. Uptake and Distribution of Anesthetic Agents, E. M. Papper, R. J. Kitz. McGraw-Hill, New York 1963; 104–119
   Google Scholar
• Severinghaus J. W. Role of lung factors. Uptake and Distribution of Anesthetic Agents, E. M. Papper, R. J. Kitz. McGrawHill, New York 1963; 59–71
   Google Scholar
• Fiserova-Bergerova V., Holaday D. A. Uptake and clearance of inhalation anesthetics in man. Drug Metab. Rev. 1979; 9: 43–60
   PubMed Web of Science ®Google Scholar
• Fiserova-Bergerova V., Vlach J., Singhal K. Simulation and prediction of uptake, distribution, and exhalation of organic solvents. Br. J. Ind. Med. 1974; 31: 45–52
   PubMedGoogle Scholar
• Fiserova-Bergerova V., Vlach J., Cassady J. D. Predictable “individual differences” in uptake and excretion of gases and lipid soluble vapours: simulation study. Br. J. Ind. Med. 1980; 37: 42–49
   PubMedGoogle Scholar
• Fiserova-Bergerova V. Biokinetics of inhalation anesthetics. Convegno Rischio provessionale da anestetici per inalazione; monitoraggio e prevenzione, E. Capodaglio, A. Mapelli. LaGoliardica Pavese, PaviaItaly 1988; 1–40
   Google Scholar
• Vlach J., Simulation. Modeling of Inhalation Exposure to Vapors: Uptake Distribution, and Elimination, V. Fiserova-Bergerova. CRC Press, Boca Raton, FL 1983; 133–153
   Google Scholar
• Fiserova-Bergerova V., Tichy M., Di Carlo F. J. Effects of biosolubility on pulmonary uptake and disposition of gases and vapors of lipophilic chemicals. Drug Metab. Rev. 1984; 15: 1033–1070
   PubMed Web of Science ®Google Scholar
• Fiserova-Bergerova V. Toxicokinetics of organic solvents. Scand. J. Work Environ. Health 1985; 11: 7–21
   PubMed Web of Science ®Google Scholar
• Fiserova-Bergerova V. Application of toxicokinetic models to establish biological exposure indicators. Ann. Occup. Hyg. 1990; 34: 639–651
   PubMed Web of Science ®Google Scholar
• Droz P. O., Guillemin M. P. Human styrene exposure. V. Development of a model for biological monitoring. Int. Arch. Occup. Environ. Health 1983; 53: 19–36
   PubMed Web of Science ®Google Scholar
• Droz P. O., Wu M. M., Cumberland W. G. Variability in biological monitoring of solvent exposure. I. Development of a population physiological model. Br. J. Ind. Med. 1989; 46: 447–460
   PubMedGoogle Scholar
• Perbellini L., Mozzo P., Brugnone F., Zedde A. Physiologicomathematical model for studying human exposure to organic solvents: Kinetics of blood/tissue n-hexane concentrations and of 2,5-hexanedione in urine. Br. J. Ind. Med. 1986; 43: 760–768
   PubMedGoogle Scholar
• Ramsey J. C., Andersen M. E. A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol. Appl. Pharmacol. 1984; 73: 159–175
   PubMed Web of Science ®Google Scholar
• Andersen M. E., MacNaughton M. G., Clewell H. J., III, Paustenbach D. J. Adjusting exposure limits for long and short exposure periods using a physiological pharmacokinetic model. Am. Ind. Hyg. Assoc. J. 1987; 48: 335–343
   PubMed Web of Science ®Google Scholar
• Carpenter R. L., Eger E. I., II., Johnson B. H., Unadkat J. D., Sheiner L. B. Pharmacokinetics of inhaled anesthetics in humans: Measurements during and after the simultaneous administration of enflurane, halothane, isoflurane, methoxyflurane, and nitrous oxide. Anesth. Analg. 1986; 65: 575–582
   PubMed Web of Science ®Google Scholar
• Carpenter R. L., Eger E. I., II., Johnson B. H., Unadkat J. D., Sheiner L. B. Does the duration of anesthetic administration affect the pharmacokinetics or metabolism of inhaled anesthetics in humans. Anesth. Analg. 1987; 66: 1–8
   PubMed Web of Science ®Google Scholar
• Carpenter R. L., Eger E. I., II., Johnson B. H., Unadkat J. D., Sheiner L. B. The extent of metabolism of inhaled anesthetics in humans. Anesthesiology 1986; 65: 201–205
   PubMed Web of Science ®Google Scholar
• Yasuda N., Lockhart S. H., Eger E. I., II., Weiskopf R. B., Liu J., Laster M., Taheri S., Peterson N. A. Comparison of kinetics of sevoflurane and isoflurane in humans. Anesth. Analg. 1991; 72: 316–324
   PubMed Web of Science ®Google Scholar
• Yasuda N., Lockhart S. H., Eger E. I., II., Weiskopf R. B., Johnson B. H., Freire B. A., Fassoulaki A. Kinetics of desflurane, isoflurane, and halothane in humans. Anesthesiology 1991; 74: 489–498
   PubMed Web of Science ®Google Scholar
• International Commission on Radiological Protection. Report of the Task Group on Reference Man, ICRP Publ. 23. Pergamon Press, New York 1975; 43–45
   Google Scholar
• Fiserova-Bergerova V. Gases and their solubility: A review of fundamentals. Modeling of Inhalation Exposure to Vapors: Uptake, Distribution, and Elimination, V. Fiserova-Bergerova. CRC Press, Boca Raton, FL 1983; Vol. 1: 3–28
   Google Scholar
• Yasuda N., Targ A. G., Eger E. I., II. Solubility of I-653, sevoflurane, isoflurane, and halothane in human tissues. Anesth. Analg. 1989; 69: 370–373
   PubMed Web of Science ®Google Scholar
• Fiserova-Bergerova V., Kawiecki R. W. Effects of exposure concentrations on distribution of halothane metabolites in the body. Drug Metab. Dispos. 1984; 12: 98–105
   PubMed Web of Science ®Google Scholar
• Fiserova-Bergerova V. Inhibitory effect of isoflurane upon oxidative metabolism of halothane. Anesth. Analg. 1984; 63: 399–404
   PubMed Web of Science ®Google Scholar
• Fiserova-Bergerova V., Dolan D. F. Transient inhibitory effect of isoflurane upon oxidative halothane metabolism. Anesth. Analg. 1985; 64: 1171–1177
   PubMed Web of Science ®Google Scholar
• Fish K. J., Rice S. A. Halothane inhibits metabolism of enflurane in Fischer 344 rats. Anesthesiology 1983; 59: 417–420
   PubMed Web of Science ®Google Scholar
• Fiserova-Bergerova V. Simulation model for concentration dependent metabolic clearance of halothane. Anesthesiology 1983; 59: A223
   Google Scholar
• Fiserova-Bergerova V. Introduction to mathematical model. Modeling of Inhalation Exposure to Vapors: Uptake, Distribution, and Elimination, V. Fiserova-Bergerova. CRC Press, Boca Raton, FL 1983; 51–70
   Google Scholar
• Levy G., Tsuchiya T., Amsel L. P. Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man. Clin. Pharmacol. Ther. 1972; 13: 258–268
   PubMed Web of Science ®Google Scholar
• Astrand I. Effect of physical exercise on uptake, distribution and elimination of vapors in man. Modeling of Inhalation Exposure to Vapors: Uptake, Distribution, and Elimination, V. Fiserova-Bergerova. CRC Press, Boca Raton, FL 1983; 107–130
   Google Scholar
• Skerlj B. Age changes in fat distribution in the female body. Acta Anat. 1959; 38: 56–63
   PubMedGoogle Scholar
• Keys A., Brozek J. Body fat in adult man. Physiol. Rev. 1953; 33: 245–325
   PubMed Web of Science ®Google Scholar